arrow
返回
M

Mohammed Milhem

University of Iowa Hospitals and Clinics

67H指数
502论文数
5.2W被引数
收录论文 86
发表时间
A Phase 1/2 study of ontorpacept (TTI-621) in combination with doxorubicin in patients with unresectable or metastatic high-grade leiomyosarcomaI期/II期研究:ontorpacept(TTI-621)联合多柔比星治疗不可切除或转移性高级别平滑肌肉瘤患者的疗效
err2026-08-04
err0
PREAI
errSujana Movva; Victoria Allgood; Rashmi Chugh; Lara E. Davis; Howard H. Bailey; Mohammed Milhem; Varun Monga; Steven Attia; Ankit Mangla; Ingmar Bruns; Luke Kuttschreuter; Dalila Bouyoucef-Cherchalli; Caimiao Wei; Gloria H. Y. Lin; Hong Zhang; Ilan Pomerance; Mihaela Druta; Sant Chawla
err分享
err收藏
Safety of the BRD9 heterobifunctional degrader CFT8634 in synovial sarcoma and SMARCB1-null tumors: an open-label, dose-escalation, phase 1 clinical trialBRD9异双功能降解剂CFT8634在滑膜肉瘤和SMARCB1缺失肿瘤中的安全性:一项开放标签、剂量递增的1期临床试验
err2026-08-04
err0
errOAAI
errBrian A. Van Tine; William D. Tap; Mark Agulnik; Ravin Ratan; Sant P. Chawla; Steven Attia; Anthony Elias; Prabhjot Mundi; Mohammed Milhem; Joseph G. Pressey; Amro Ali; Ingrid Mintautas; Riadh Lobbardi; Huan Liu; Eunju Hurh; Len Reyno; Gregory M. Cote
err分享
err收藏
Late recurrence of Wilms tumor after a 32−year disease−free interval: case report and literature reviewWilms肿瘤在32年无病间隔后的晚期复发:病例报告和文献综述
err2026-04-10
err0
errOAAI
errMR Matthew R. Kroll; RL Rachaita Lakra; JJ Jonathan J. Davick; JG Jenna Gedminas; MM Mohammed Milhem; SC Sara C. Horton
err分享
err收藏
Abemaciclib in meningiomas with somatic NF2 or CDK pathway alterations: the phase 2 Alliance A071401 trialAbemaciclib在具有体细胞NF2或CDK途径改变的脑膜瘤中的应用: 2期联盟A071401试验
err2026-01-16
err0
errOAAI
errPriscilla K. Brastianos; Katharine Dooley; Susan Geyer; Elizabeth R. Gerstner; Timothy J. Kaufmann; A. John Iafrate; Maria Martinez-Lage; Mohammed Milhem; Mary Roberta Welch; Thomas J. Kaley; Jan Drappatz; Amy Chan; Priya Kumthekar; Carlos Kamiya Matsuoka; Roy E. Strowd; Adam L. Cohen; Kurt Jaeckle; Lindsay Robell; Rajiv S. Magge; Joo Yeon Nam; Nicholas Blondin; Nawal Shaikh; Ian Rabinowitz; Alissa A. Thomas; David E. Piccioni; Paul Brown; Stefan Kaluziak; Elizabeth Codd; Daniel P. Cahill; Sandro Santagata; Frederick G. Barker; Evanthia Galanis
err分享
err收藏
Vascular Leiomyosarcoma Masquerading as Chronic Deep Venous Thrombosis
err2025-12-11
err0
errOAAI
errPhillips, Isabella BS; Chen, Jason BS; Milhem, Mohammed MBBS†; DiCamillo, Paul MD, PhD‡; Pollard, Janet MD‡
err分享
err收藏
Phase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors晚期实体瘤患者AXL特异性抗体药物偶联物Enapotamab Vedotin的I/II期研究
err2025-11-01
err0
errOAAI
errRohrberg, Kristoffer Staal; Lopez, Juanita S.; Milhem, Mohammed M.; Blank, Christian U.; Reijers, Irene; Thistlethwaite, Fiona; Plummer, Ruth; Piha-Paul, Sarina A.; Janne, Pasi A.; Shum, Elaine; Shaw, Heather M.; Debruyne, Philip R.; Lao, Cristopher; Baurain, Jean-Francois; Choe, Jennifer H.; Gort, Eelke; Zhao, Yujie; Jerusalem, Guy; Schoffski, Patrick; Chen, Andrew William; Cohen, Eric A.; Mankowski, Walter C.; Roshkovan, Leonid; Katz, Sharyn I.; Kontos, Despina; Brady, Lauren K.; Qutaish, Mohammed; Castro, Patricia Garrido; Pencheva, Nora; Bajaj, Gaurav; Fu, Yali; Windfeld, Kristian; Reiter, Panagiota; Jure-Kunkel, Maria; Higgs, Brandon W.; Amiri, Katayoun I.; Ahmadi, Tahamtan; Forssmann, Ulf; Ramalingam, Suresh S.; Vergote, Ignace
err分享
err收藏
Intratumoral vidutolimod as monotherapy or in combination with pembrolizumab in patients with programmed cell death 1 blockade–resistant melanoma: Final analysis from a phase 1b study肿瘤内注射vidutolimod作为单药治疗或与pembrolizumab联用,用于程序性细胞死亡1阻滞剂耐药性黑色素瘤患者的最终分析:一项1b期研究的结果
errCancer
IF5.1
err2025-08-03
err0
errOAAI
errMohammed M. Milhem MD; Yousef Zakharia MD; Diwakar Davar MD, MSc; Elizabeth I. Buchbinder MD; Theresa Medina MD; Adil Daud MD; Antoni Ribas MD, PhD; Bartosz Chmielowski MD, PhD; Jiaxin Niu MD, PhD; Geoffrey T. Gibney MD; Kim Margolin MD, FASCO; Anthony J. Olszanski RPh, MD; Inderjit Mehmi MD; Takami Sato MD, PhD; Montaser Shaheen MD; Luping Zhao PhD; Heather Kelley MA; Hong Liu PhD; Sujatha Kumar PhD; Dmitri Bobilev MD; Arthur M. Krieg MD; James E. Wooldridge MD; John M. Kirkwood MD
err分享
err收藏
Phase 1 study of IMCnyeso, a T cell receptor bispecific ImmTAC targeting NY-ESO-1-expressing malignanciesI期IMCnyeso研究,该研究是一种靶向NY-ESO-1表达性恶性病变的T细胞受体双特异性ImmTAC。
err2025-04-01
err0
errOAAI
errLopez, Juanita S.; Milhem, Mohammed; Butler, Marcus O.; Thistlethwaite, Fiona; Van Tine, Brian A.; D'Angelo, Sandra P.; Johnson, Melissa L.; Sato, Takami; Arkenau, Hendrik-Tobias; Edukulla, Ramakrishna; Wustner, Jason; Marshall, Shannon; Rodon, Jordi
err分享
err收藏
ALLIANCE A071401: GENOMICALLY GUIDED PHASE II TRIAL OF ABEMACICLIB IN PATIENTS WITH GRADE 2/3 MENINGIOMAS HARBORING SOMATIC NF2 OR CDK PATHWAY ALTERATIONS
err2024-11-11
err0
PREAI
errBrastianos, Priscilla; Dooley, Katharine; Geyer, Susan; Gerstner, Elizabeth; Kaufmann, Timothy; Iafrate, A. John; Martinez-Lage, Maria; Milhem, Mohammed; Welch, Mary; Kaley, Thomas; Drappatz, Jan; Chan, Amy; Kumthekar, Priya; Matsuoka, Carlos Kamiya; Strowd, Roy; Cohen, Adam; Jaeckle, Kurt; Robell, Lindsay; Magge, Rajiv; Nam, Joo Yeon; Blondin, Nicholas; Shaikh, Nawal; Rabinowitz, Ian; Thomas, Alissa; Cahill, Daniel; Santagata, Sandro; Barker, Frederick; Galanis, Evanthia
err分享
err收藏
A multicenter, randomized, non-comparative, phase II study of nivolumab ± ipilimumab for patients with metastatic sarcoma (Alliance A091401): expansion cohorts and correlative analyses
err2024-09-28
err0
errOAAI
errSeligson, Nathan D.; Chen, James L.; Goodrich, Austin C.; Van Tine, Brian A.; Campbell, Jordan D.; Richards, Allison L.; Antonescu, Cristina R.; Liebner, David A.; Milhem, Mohammed M.; Streicher, Howard; Tap, William D.; Schwartz, Gary K.; George, Suzanne; D'Angelo, Sandra P.
err分享
err收藏
Primary efficacy, safety, and survival data from the registration-intended cohort of patients with anti-PD-1-failed melanoma from the IGNYTE clinical trial with RP1 combined with nivolumab来自IGNYTE临床试验中RP1联合nivolumab治疗组的、抗PD-1治疗失败的黑色素瘤患者注册意向队列的初步有效性、安全性和生存数据
err2024-09-01
err2
PREAI
errRobert, C.; Milhem, M. M.; Sacco, J. J.; Michels, J.; In, G. K.; Munoz-Couselo, E.; Schadendorf, D.; Beasley, G. M.; Niu, J. J.; Chmielowski, B.; Wise-Draper, T. M.; Bowles, T. L.; Tsai, K. K.; Lebbe, C.; Marqueste, C. Gaudy; Middleton, M. R.; Samson, A.; Zhu, J.; Viana, M.; Wong, M. K. K.
err分享
err收藏
Phase 1b trial Mipasetamab Uzoptirine (ADCT-601-102) dose escalation in patients with advanced bone and soft tissue sarcomas
err2024-04-05
err0
PREAI
errVan Tine, Brian Andrew; Chen, Christopher T.; Moreno, Victor; Davis, Elizabeth J.; de Miguel, Maria J.; Italiano, Antoine; Saada-Bouzid, Esma; Milhem, Mohammed; Valverde, Claudia; Chawla, Sant P.; Naqash, Abdul Rafeh; Carter, Louise; Jones, Robin; Conti, Ilaria; Boni, Joe; Havenith, Karin; LeBruchec, Yvan; Pantano, Serafino; Blay, Jean-Yves
err分享
err收藏
Phase 1 study of MDM2 antagonist ASTX295 in patients with solid tumors with wild-type TP53
err2024-04-05
err1
PREAI
errDumbrava, Ecaterina E.; Iwamoto, Fabio M.; Agulnik, Mark; Milhem, Mohammed; Tolcher, Anthony W.; Chugh, Rashmi; Demeure, Michael J.; Mita, Alain; Demel, Kurt; Diamond, Mark; Mirakhur, Beloo; Wilson, Laksmi; Oganesian, Aram; Chan, Danna; Keer, Harold N.; Taylor, Jason; Sims, Martin J.; Biondo, Andrea; Jueliger, Simone; Spira, Alexander
err分享
err收藏
Three-Year Overall Survival with Tebentafusp in Metastatic Uveal MelanomaTebentafusp治疗转移性葡萄膜黑色素瘤的三年总生存率
err2023-12-14
err49
errOAAI
errHassel, Jessica C.; Piperno-Neumann, Sophie; Rutkowski, Piotr; Baurain, Jean-Francois; Schlaak, Max; Butler, Marcus O.; Sullivan, Ryan J.; Dummer, Reinhard; Kirkwood, John M.; Orloff, Marlana; Sacco, Joseph J.; Ochsenreither, Sebastian; Joshua, Anthony M.; Gastaud, Lauris; Curti, Brendan; Piulats, Josep M.; Salama, April K. S.; Shoushtari, Alexander N.; Demidov, Lev; Milhem, Mohammed; Chmielowski, Bartosz; Kim, Kevin B.; Carvajal, Richard D.; Hamid, Omid; Collins, Laura; Ranade, Koustubh; Holland, Chris; Pfeiffer, Constance; Nathan, Paul
err分享
err收藏
Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I Trial
err2023-06-28
err9
errOAAI
errEllingsen, Espen B.; O'Day, Steven; Mezheyeuski, Artur; Gromadka, Agnieszka; Clancy, Trevor; Kristedja, Timothy S.; Milhem, Mohammed; Zakharia, Yousef
err分享
err收藏
Talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone for advanced melanoma: 5-year final analysis of a multicenter, randomized, open- label, phase II trial
err2023-05-04
err31
errOAAI
errChesney, Jason A.; Puzanov, Igor; Collichio, Frances A.; Singh, Parminder; Milhem, Mohammed M.; Glaspy, John; Hamid, Omid; Ross, Merrick; Friedlander, Philip; Garbe, Claus; Logan, Theodore; Hauschild, Axel; Lebbe, Celeste; Joshi, Harshada; Snyder, Wendy; Mehnert, Janice M.
err分享
err收藏
A phase 1, open-label, dose-escalation study of PRT1419, a selective induced myeloid leukemia cell differentiation protein (MCL-1) inhibitor, in patients (pts) with advanced/metastatic solid tumors
err2023-04-14
err2
PREAI
errFalchook, Gerald; Patel, Manish; McKean, Meredith; Philipovskiy, Alexander; Chiaverelli, Rachel; Sun, William; Fossler, Michael; Novotny, William; Kurman, Michael; Rowe, Sarah; Hunter, Deborah; Milhem, Mohammed
err分享
err收藏
Phase 1/2 study of the safety, pharmacokinetics, and preliminary clinical activity of BT7480 in patients with nectin-4 associated advanced malignancies
err2023-04-14
err0
PREAI
errEvans, Thomas R.; Dowlati, Afshin; Lopez, Juanita S.; Milhem, Mohammed M.; Ahnert, Jordi Rodon; Spira, Alexander; Carvajal, Richard D.; Zibelman, Matthew; Hazard, Sebastien J.; Dickson, Amy; Xu, Lei; Cohen, Heather; Bader, Justin; Hurov, Kristen; Sharma, Rajiv; Smethurst, Dominic; Papadopoulos, Kyriakos P.
err分享
err收藏